Date: 06th June, 2026
Regulatory Compliance Disclosure
Balaxi Pharmaceuticals Limited submitted a regulatory compliance report to the National Stock Exchange of India Limited regarding physical share transfer re-lodgement requests as mandated by SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/ I/3750/2026 dated 30th January, 2026.
The report covers the period ended May 2026 and was prepared by the company's Registrar and Share Transfer Agent, M/s. Aarthi Consultants Private Limited.
Physical Share Transfer Request Status
The report confirms that for the month of May 2026:
- Number of requests received during the month: NIL
- Number of requests processed during the month: NIL
- Number of requests approved during the month: NIL
- Number of requests rejected during the month: NIL
- Average time taken for processing of requests: NA (not applicable)
Additional Information
The report has been made available on the company's website at www.balaxipharma.in for shareholder reference.
Signatories and Authentication
The RTA report from Aarthi Consultants Private Limited was signed by Jagan Mohan Gobburi, Compliance Officer, dated 06/06/2026.